MoneyWorks4Me

Biocon enters into collaboration with Ypsomed

13 Apr 2017 Evaluate

Biocon has enter into collaboration with Ypsomed to customize the latter’s reusable YpsoPen for use with Biocon’s insulin cartridges. This customized reusable pen will be marketed by Biocon as INSUPen Pro in Malaysia.

Biocon has set up one of Asia’s largest integrated insulin manufacturing facility in Malaysia and has introduced its Insugen and INSUPen Pro brands in the local market recently. Ypsomed’s high quality reusable pen compliments Biocon’s Insulins product portfolio and enables Biocon to further address the growing needs of people with diabetes in Malaysia.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Peers
Company Name CMP
Sun Pharma. Inds. 1786.60
Dr. Reddys Labs. 1198.50
Cipla 1335.80
Lupin 2012.05
Zydus Lifesciences 1141.00
View more..